Tag: Viking Therapeutics

Viking Therapeutics has captured significant market attention with its recent stock performance, demonstrating strong upward momentum following analyst confirmation of ...

Viking Therapeutics shares delivered a contradictory performance on Tuesday, advancing 1.86 percent to reach $27.88 and outpacing the S&P 500's ...

The obesity treatment market is witnessing renewed speculation around potential consolidation, with Viking Therapeutics positioned at the center of these ...

Viking Therapeutics finds itself at a critical investment crossroads, pulled in opposite directions by two powerful market forces. Soaring takeover ...

Viking Therapeutics finds itself navigating complex challenges as it advances its obesity treatment portfolio. The company's oral drug candidate, VK2735, ...

Shares of Viking Therapeutics experienced a notable upswing this week, climbing 7.4% on Wednesday to close at $26.82. The catalyst ...

Shares of Viking Therapeutics are experiencing significant turbulence as conflicting forces within the biotechnology sector create a challenging landscape for ...

Viking Therapeutics experienced significant selling pressure yesterday as investors reacted to Pfizer's unexpected acquisition of competitor Metsera. The biotech firm's ...

Viking Therapeutics shares are entering a pivotal period as the market anticipates key developments. Following August's volatility triggered by disappointing ...

Viking Therapeutics shares registered substantial double-digit gains late last week, propelled by favorable sector developments and sustained bullish sentiment among ...